CardioLogs ECG Analysis Platform vs qXR-CTR

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by CardioLogs (acquired by Philips in 2021)
VS
by Qure.ai

AI Verdict

Tool A specializes in AI-powered analysis of ECG data for arrhythmia detection across various cardiac monitoring devices. Conversely, Tool B focuses on automating cardiothoracic ratio measurement from chest X-ray images to assess heart size and heart failure risk. While both are cardiology AI tools, their distinct input modalities and diagnostic applications mean they address different aspects of cardiac assessment.

Choose CardioLogs ECG Analysis Platform if…

Choose CardioLogs ECG Analysis Platform if your primary need is comprehensive, AI-driven analysis of diverse ECG data sources, including Holter monitors, smartwatches, and ECG patches. This platform is ideal for clinicians requiring rapid and accurate arrhythmia detection and diagnosis across a wide range of cardiac monitoring devices, with the added benefit of customizable reports and EHR integration.

View CardioLogs ECG Analysis Platform →

Choose qXR-CTR if…

Choose qXR-CTR if your focus is specifically on the automated and efficient measurement of the cardiothoracic ratio from chest X-ray images. This tool is best suited for scenarios where a quick, AI-powered assessment of heart size and potential heart failure risk from X-rays is a critical initial screening or diagnostic step.

View qXR-CTR →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature CardioLogs ECG Analysis Platform qXR-CTR
Deployment Cloud-based Can be deployed on cloud or on-premise. The Qure.ai app receives DICOM studies via DICOM network protocol from medical systems (PACS/Modality) or can import DICOM from the local system. The received DICOM study is processed in Qure's cloud server, and AI-processed reports are displayed on the app.
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

CardioLogs ECG Analysis Platform

Tool A, the CardioLogs ECG Analysis Platform, offers features like customizable reports and integration with EHR systems, which enhance its adaptability to various clinical workflows. While Tool B automates a specific task, Tool A's broader platform capabilities suggest a more comprehensive and versatile user experience for clinicians.

Clinical Value

CardioLogs ECG Analysis Platform

Both tools are FDA cleared and address important clinical needs. However, Tool A provides medical-grade AI for rapid and efficient analysis of ECG data from multiple devices, including smartwatches, aiding in the detection and diagnosis of a wide range of arrhythmias. This broader diagnostic capability offers more comprehensive clinical utility compared to Tool B's focused cardiothoracic ratio assessment.

Pricing & Value

CardioLogs ECG Analysis Platform

Tool A offers a more transparent pricing model by stating 'Pay per ECG regardless of the number of users,' which allows potential customers to better understand and budget for costs. In contrast, Tool B's pricing details are not publicly disclosed, making it harder to assess its value proposition upfront.

Enterprise Readiness

qXR-CTR

Tool B, qXR-CTR, offers greater flexibility for enterprise deployment with options for cloud, on-premise, and hybrid models. This adaptability is crucial for organizations with diverse IT infrastructure requirements or specific data residency policies, whereas Tool A is primarily cloud-based.

Innovation

CardioLogs ECG Analysis Platform

Tool A demonstrates higher innovation by explicitly mentioning the use of 'Deep Neural Networks' and 'Multi-Device Compatibility,' including modern devices like smartwatches, for comprehensive ECG analysis. This indicates a more advanced and integrated approach to leveraging AI in diagnostics compared to Tool B's more focused automation of CTR measurement.

Support & Docs

qXR-CTR

Tool B provides explicit details on its support, including a dedicated client success partner, 24/7 support, and a typical response time of less than 6 hours, along with in-app features for reporting issues and suggesting ideas. While Tool A, as part of Philips, has general support channels, it lacks the specific, proactive support details offered by Tool B.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature CardioLogs ECG Analysis Platform qXR-CTR
Name CardioLogs ECG Analysis Platform qXR-CTR
Company Cardiologs Technologies (now part of Philips) Qure.ai Technologies
Primary Function Rapid, accurate, and efficient analysis of ECG data from various cardiac monitoring devices, aiding physicians in arrhythmia detection and diagnosis. Automates the measurement of the cardiothoracic ratio (CTR) from chest X-ray images, aiding in the assessment of heart size and potential heart failure risk.
Categories Cardiology AI Cardiology AI, Radiology & Imaging AI
Specialties Cardiology, Emergency Medicine, Internal Medicine Cardiology, Radiology

Videos

Demos, reviews, and walkthroughs featuring CardioLogs ECG Analysis Platform and qXR-CTR.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The CardioLogs ECG Analysis Platform analyzes ECG data from various cardiac monitoring devices to aid in arrhythmia detection and diagnosis. In contrast, qXR-CTR analyzes chest X-ray images to automate the measurement of the cardiothoracic ratio (CTR).
CardioLogs is designed to assist physicians with rapid, accurate, and efficient analysis of ECG data for arrhythmia detection and diagnosis. qXR-CTR aids in the assessment of heart size and potential heart failure risk by automating the measurement of the cardiothoracic ratio from chest X-rays.
CardioLogs targets Cardiology, Emergency Medicine, and Internal Medicine. qXR-CTR primarily targets Cardiology and Radiology.
The CardioLogs ECG Analysis Platform lists real-time monitoring/analysis as a key feature. Real-time monitoring is not explicitly listed as a feature for qXR-CTR, which focuses on automated measurement from static X-ray images.
AI Tool Finder
AI-powered search. Results may not be comprehensive.